[go: up one dir, main page]

EP1999270A4 - Substrates and internal standards for mass spectroscopy detection - Google Patents

Substrates and internal standards for mass spectroscopy detection

Info

Publication number
EP1999270A4
EP1999270A4 EP07758446A EP07758446A EP1999270A4 EP 1999270 A4 EP1999270 A4 EP 1999270A4 EP 07758446 A EP07758446 A EP 07758446A EP 07758446 A EP07758446 A EP 07758446A EP 1999270 A4 EP1999270 A4 EP 1999270A4
Authority
EP
European Patent Office
Prior art keywords
substrates
mass spectroscopy
internal standards
spectroscopy detection
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07758446A
Other languages
German (de)
French (fr)
Other versions
EP1999270A2 (en
Inventor
Blas Cerda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revvity Health Sciences Inc
Original Assignee
PerkinElmer LAS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PerkinElmer LAS Inc filed Critical PerkinElmer LAS Inc
Publication of EP1999270A2 publication Critical patent/EP1999270A2/en
Publication of EP1999270A4 publication Critical patent/EP1999270A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
EP07758446A 2006-03-13 2007-03-13 Substrates and internal standards for mass spectroscopy detection Withdrawn EP1999270A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78185506P 2006-03-13 2006-03-13
PCT/US2007/063894 WO2007106816A2 (en) 2006-03-13 2007-03-13 Substrates and internal standards for mass spectroscopy detection

Publications (2)

Publication Number Publication Date
EP1999270A2 EP1999270A2 (en) 2008-12-10
EP1999270A4 true EP1999270A4 (en) 2010-04-28

Family

ID=38510237

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07758446A Withdrawn EP1999270A4 (en) 2006-03-13 2007-03-13 Substrates and internal standards for mass spectroscopy detection

Country Status (8)

Country Link
US (1) US8476414B2 (en)
EP (1) EP1999270A4 (en)
JP (1) JP2009530310A (en)
CN (2) CN102943106A (en)
AU (1) AU2007226582B2 (en)
BR (1) BRPI0709289A2 (en)
CA (1) CA2646505A1 (en)
WO (1) WO2007106816A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102014929A (en) * 2008-03-13 2011-04-13 珀金埃尔默健康科学有限公司 Enzymatic substrates for multiple detection systems
EP2249140B1 (en) * 2009-05-07 2018-06-27 F. Hoffmann-La Roche AG Method for excising biological samples on a solid support
WO2011063048A2 (en) * 2009-11-17 2011-05-26 Baylor Research Institute Urinary triaosylceramide (gb3) as a marker of cardiac disease
WO2012027612A1 (en) * 2010-08-25 2012-03-01 Michael Gelb Mass spectrometric compositions and methods for lysosomal storage disease screening
CN105247068A (en) * 2013-03-15 2016-01-13 珀金埃尔默健康科学股份有限公司 Compounds and methods related to testing for lysosomal storage disorders
GB201305986D0 (en) * 2013-04-03 2013-05-15 Asociaci N Ct De Investigaci N Cooperativa En Biomateriales Synthesis and use of isotopically-labelled glycans
US9575064B2 (en) * 2014-09-02 2017-02-21 Perkinelmer Health Sciences, Inc. Methods relating to testing for lysosomal storage disorders
WO2017127670A1 (en) * 2016-01-22 2017-07-27 Purdue Research Foundation Charged mass labeling system
US10774064B2 (en) 2016-06-02 2020-09-15 Cadent Therapeutics, Inc. Potassium channel modulators
CN109311803A (en) * 2016-06-29 2019-02-05 株式会社日立高新技术 Compounds used in enzymatic reactions and mass analysis methods
JP6997197B2 (en) 2017-01-23 2022-01-17 カデント セラピューティクス,インコーポレーテッド Potassium channel modulator
EP3422005B1 (en) 2017-06-27 2020-05-13 Medizinische Universität Graz Determining enrichments of tracers of glucose by mass spectrometry
US10656059B2 (en) * 2018-03-07 2020-05-19 Alcala Pharmaceutical, Inc. Method for qualitative and quantitative multiplexing of drug analytes from biological samples
UY38238A (en) * 2018-05-25 2019-12-31 Genzyme Corp PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACID SPHINGOMYELINASE DEFICIENCY
MX2021004647A (en) 2018-10-22 2021-08-16 Novartis Ag Crystalline forms of potassium channel modulators.
CN111269280B (en) * 2020-03-27 2021-07-13 江苏豪思睦可生物科技有限公司 Compound, corresponding internal standard and kit for detecting enzyme related to lysosomal storage disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968785A (en) * 1988-05-17 1990-11-06 Henkel Kommanditgesellschaft Auf Aktien Substituted glycoside compositions
US5138043A (en) * 1989-12-07 1992-08-11 Union Carbide Chemicals & Plastics Technology Corporation Alkoxylated alkyl glucoside ether quaternaries useful in personal care
JPH08145948A (en) * 1994-11-16 1996-06-07 Sumitomo Chem Co Ltd Mass spectrometry of reducing oligosaccharides
US6645644B1 (en) * 1996-10-17 2003-11-11 The Trustees Of Princeton University Enhanced bonding of phosphoric and phosphoric acids to oxidized substrates
FR2767134B1 (en) * 1997-08-08 1999-09-24 Ceca Sa N-(DIALKYLAMINO)ALKYL GLYCOSYLAMINES AND DERIVATIVES, PROCESSES FOR THE PREPARATION, COMPOSITION CONTAINING THEM AND USES, PARTICULARLY IN THE FIELD OF COSMETICS.
ATE253126T1 (en) * 1998-08-25 2003-11-15 Univ Washington RAPID QUANTITATIVE ANALYSIS OF PROTEINS OR PROTEIN FUNCTIONS IN COMPLEX MIXTURES

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LI YIJUN ET AL: "Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening", CLINICAL CHEMISTRY, AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, WASHINGTON, DC, vol. 50, no. 10, 1 October 2004 (2004-10-01), pages 1785 - 1796, XP002514511, ISSN: 0009-9147 *
MICHAEL H GELB ET AL: "Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders", JOURNAL OF INHERITED METABOLIC DISEASE, KLUWER ACADEMIC PUBLISHERS, DO, vol. 29, no. 2-3, 9 July 2005 (2005-07-09) - 1 April 2006 (2006-04-01), pages 397 - 404, XP019392093, ISSN: 1573-2665 *
OKUMIYA T ET AL: "A new diagnostic assay for glycogen storage disease type II in mixed leukocytes", MOLECULAR GENETICS AND METABOLISM, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 88, no. 1, 15 December 2005 (2005-12-15), pages 22 - 28, XP024947041, ISSN: 1096-7192, [retrieved on 20060501] *

Also Published As

Publication number Publication date
BRPI0709289A2 (en) 2011-07-05
US8476414B2 (en) 2013-07-02
EP1999270A2 (en) 2008-12-10
WO2007106816A3 (en) 2008-08-21
CN101426926A (en) 2009-05-06
JP2009530310A (en) 2009-08-27
CA2646505A1 (en) 2007-09-20
AU2007226582B2 (en) 2012-07-05
US20090068634A1 (en) 2009-03-12
CN102943106A (en) 2013-02-27
AU2007226582A1 (en) 2007-09-20
WO2007106816A2 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
EP1999270A4 (en) Substrates and internal standards for mass spectroscopy detection
PL2092172T3 (en) Gas intake device
EP2006672A4 (en) Gas analyzer
TWI349968B (en) Substrate processing device and substrate processing method thereof
EP2004626A4 (en) Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
EP2001476A4 (en) Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
EP2086326A4 (en) Cyclohexenyl-aryl compounds for inflammation and immune-related uses
EP2042853A4 (en) Analyzer and use thereof
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
GB0622450D0 (en) Devices and methods for detecting haematin and haemozoin
EP2010677A4 (en) Methods and compositions for detecting polynucleotides
EP2100110A4 (en) Microspectrometer gas analyzer
EP2185725A4 (en) Compositions and methods for analyte detection and quantitation
GB2436623B (en) Microtome
IL194867A0 (en) Device and method for the reduction of emissions
GB2445272B (en) Gas filtering-buffering device
EP2026081A4 (en) Test device and test method
IL192112A0 (en) Compositions and articles for detection of analytes exceeding a preset-tereshold
PL1806205T3 (en) Method for mounting internal O-rings and device for carrying out the method
GB0601959D0 (en) Sepsis test
EP1976440A4 (en) Device and method for anastomosis
EP1988385A4 (en) Nitrogen analyzer
IL198413A0 (en) Sugar coatings and methods therefor
GB0604914D0 (en) Calibration device and method
GB2439439A9 (en) Measurement device and method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081007

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20100330

17Q First examination report despatched

Effective date: 20100702

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20130715

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20131126